medical-blog
Last updated: 2018-07-30

Fukuoka Cancer Comprehensive Clinic: Apheresis Technology and Advanced Lymphocyte Immunotherapy

S
Medical Supporter Team
Cross-border medical coordination and editorial review team
Fukuoka Cancer Comprehensive Clinic: Apheresis Technology and Advanced Lymphocyte Immunotherapy

Fukuoka Cancer Comprehensive Clinic: Advanced Apheresis and Cell Therapy

Medical Supporter — Information Notice

This article is a summary of international medical information and is not medical advice; it cannot replace the diagnosis or treatment plan of your attending physician. The medical technologies, drug information and clinical data presented here are compiled from public literature and official statements of major Japanese medical institutions; the applicability and outcome of any therapy vary with each patient and must be assessed individually by a qualified physician.

Any specific treatment plan must be assessed by a licensed physician in Japan

Fukuoka Cancer Comprehensive Clinic represents a strategic partnership with Medical Supporter. Under the leadership of Dr. Takashi Morisaki, leveraging extensive clinical research experience at Kyushu University Hospital, the clinic specializes in immune cell therapy applications for advanced cancer adjuvant treatment.

Two Core Technology Platforms

Advanced Apheresis Technology: Unlike standard whole blood collection, the clinic employs precision component apheresis systems. Immune cells (T cells, NK cells) are selectively extracted via blood separator technology, with plasma and red cells immediately returned to the patient.

Advantage: Sufficient cellular material obtained in single procedure, dramatically reducing phlebotomy burden in weakened patients.

In-House CPC Laboratory: To prevent cell damage during transport, the clinic maintains Ministry of Labor-certified Cell Processing Center (CPC) on-site.

Quality Assurance: Culture initiation within minutes of apheresis ensures maximum cell viability and cytotoxic potency upon reinfusion.

Treatment Modalities

Activated Lymphocyte Therapy: Synchronized T cell and NK cell expansion

Dendritic Cell Vaccine (DC): Tumor-specific antigen presentation strategy

Peptide Vaccine Combinations: Personalized HLA-matched peptide therapy

Data Source

Fukuoka Cancer Comprehensive Clinic Clinical Program

Medical Supporter was formerly certified as an international medical visa guarantor by Japan's Ministry of Foreign Affairs and the Ministry of Economy, Trade and Industry (B-066).

Considering medical care in Japan? Need information and support?

We help you organize the information needed for medical travel to Japan, liaise with Japanese medical institutions, and arrange a second-opinion consultation.The first consultation is free; an advisor will help you clarify the next steps.

Fukuoka HQ: +81-92-984-3200
Formerly officially certified, No. B-066

Related Reading